|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 6/12/23 Heron Therapeutics, Inc./DE 8-K:5,9 6/06/23 12:482K Donnelley … Solutions/FA |
Document/Exhibit Description Pages Size 1: 8-K Current Report HTML 169K 2: EX-3.1 Articles of Incorporation/Organization or Bylaws HTML 12K 3: EX-99.1 Miscellaneous Exhibit HTML 18K 7: R1 Document and Entity Information HTML 49K 10: XML IDEA XML File -- Filing Summary XML 12K 8: XML XBRL Instance -- hrtx-20230606_htm XML 16K 9: EXCEL IDEA Workbook of Financial Report Info XLSX 8K 5: EX-101.LAB XBRL Labels -- hrtx-20230606_lab XML 56K 6: EX-101.PRE XBRL Presentations -- hrtx-20230606_pre XML 36K 4: EX-101.SCH XBRL Schema -- hrtx-20230606 XSD 11K 11: JSON XBRL Instance as JSON Data -- MetaLinks 12± 20K 12: ZIP XBRL Zipped Folder -- 0000950170-23-027374-xbrl Zip 24K
| EX-3.1 |
Exhibit 3.1
CERTIFICATE OF AMENDMENT
TO THE CERTIFICATE OF INCORPORATION OF
HERON THERAPEUTICS, INC.
Heron Therapeutics, Inc., a corporation duly organized and existing under the General Corporation Law of the State of Delaware (the “Corporation” and the “DGCL”, respectively), does hereby certify:
FIRST: That, upon the Effective Time, Section A of Article IV of the Certificate of Incorporation of the Corporation shall be amended and restated in its entirety as follows:
“A. Authorized Capital. The Corporation is authorized to issue two classes of shares of stock to be designated, respectively, “preferred” and “common.” The total number of shares that the Corporation is authorized to issue is Two Hundred Twenty-Seven Million Five Hundred Thousand (227,500,000). The number of shares of common stock authorized to be issued is Two Hundred Twenty-Five Million (225,000,000), each such share to have a par value of $0.01 (“Common Stock”), and the number of preferred shares authorized to be issued is Two Million Five Hundred Thousand (2,500,000), each such share to have a par value of $0.01 (“Preferred Stock”).”
SECOND: The amendment to the Certificate of Incorporation of the Corporation herein was duly adopted by this Corporation’s Board of Directors in accordance with the applicable provisions of Section 242 of the DGCL. An annual meeting of the stockholders of the Corporation was duly called upon notice in accordance with Section 222 of the DGCL and held on June 8, 2023, at which meeting the necessary number of shares were voted in favor of the proposed amendment. The stockholders of the Corporation duly adopted this Certificate of Amendment in accordance with the applicable provisions of Section 242 of the DGCL.
THIRD: The amendment to the Certificate of Incorporation of the Corporation herein shall be effective June 9, 2023 at 12:01 a.m. Eastern Time (the “Effective Time”).
IN WITNESS WHEREOF, said Corporation has caused this Certificate of Amendment to be executed by its duly authorized officer this 8th day of June, 2023.
HERON THERAPEUTICS, INC.
By: /s/ Craig Collard
Name: Craig Collard
Title: Chief Executive Officer
| This ‘8-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 6/12/23 | |||
| 6/9/23 | ||||
| 6/8/23 | DEF 14A, PRE 14A | |||
| For Period end: | 6/6/23 | |||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 5/07/24 Heron Therapeutics, Inc./DE 10-Q 3/31/24 57:5.9M Donnelley … Solutions/FA 3/12/24 Heron Therapeutics, Inc./DE 10-K 12/31/23 72:10M Donnelley … Solutions/FA 9/06/23 Heron Therapeutics, Inc./DE 424B3 1:192K Donnelley … Solutions/FA 8/23/23 Heron Therapeutics, Inc./DE S-3 4:317K Donnelley … Solutions/FA 8/14/23 Heron Therapeutics, Inc./DE 10-Q 6/30/23 66:9M Donnelley … Solutions/FA 6/30/23 Heron Therapeutics, Inc./DE S-8 6/30/23 8:270K Donnelley … Solutions/FA |